Project Grant R01DK140159
Award Date
9/1/24
Completion Date
6/30/28
Dollars Obligated
$469K
Federal Grant Program
93.847
Assistance Type
Project Grant
Place of Performance
Worcester, MA 01655, USA
Similar Awards
This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), supports research to understand the role of the unfolded protein response (UPR) in the development of non-alcoholic steatohepatitis (NASH), a leading cause of liver transplantation. The $172,060 award, granted on January 9, 2025, aims to elucidate the mechanisms by which the loss of the...
This federal Project Grant award of $806,452 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), supports research to investigate the mechanisms that combine type 2 diabetes (T2D) with non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). The research, led by The Children's Hospital Corporation (doing business as Boston Children's Hospital),...
This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), is funding research to define the role of antigen-specific T cell responses in non-alcoholic steatohepatitis (NASH). The $599,541 award, made on Sep 15, 2024, with a completion date of Aug 31, 2025, aims to: (1) determine the timing of T cell clonal expansion during NASH progression; (2)...
This $707,389 Project Grant awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) supports research to evaluate the evolution of nonalcoholic fatty liver disease (NAFLD) during pregnancy and its influence on pregnancy outcomes. The study, titled "TARGETING NONALCOHOLIC FATTY LIVER DISEASE DURING THE REPRODUCTIVE PERIOD TO IMPROVE WOMEN'S HEALTH OUTCOMES,"...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), supports the development of novel small molecule modulators called Parmodulins to treat metabolic dysfunction-associated steatohepatitis (MASH), also known as non-alcoholic steatohepatitis (NASH). The $1,391,142 award to Function Therapeutics Inc. will fund research to synthesize and profile...
The U.S. Department of Health and Human Services' National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $361,400 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to Oncotrap Inc. The funding supports the development of a bispecific single-domain antibody targeting the chemokines CCL2 and CCL5 for the treatment of non-alcoholic steatohepatitis (NASH). The award will enable Oncotrap to generate a human version...
This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $243,590 to the University of Chicago to conduct research on the role of the BNIP3 protein in regulating lipid homeostasis in the liver. The key objectives are to determine whether BNIP3 promotes lipophagy (the breakdown of lipid droplets) predominantly in pericentral regions of...
This $1,596,244 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) supports research on the dysregulation of calcium signaling in the initiation of non-alcoholic fatty liver disease (NAFLD). The research aims to: 1) Identify the molecular mechanisms by which a high-fat diet suppresses calcium signaling, 2) Investigate zonal differences in calcium...
This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) provides $272,133 to support research on the role of lipid droplet proteins in regulating eicosanoid production and the progression of non-alcoholic fatty liver disease (NAFLD). The Principal Investigator will conduct a "recall-by-genotype" study to deeply phenotype subjects with the PNPLA3-I148M...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK, CFDA 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research) provides $293,543 to Furanica, Inc. to develop a novel compound, FAL-113, for the treatment of nonalcoholic steatohepatitis (NASH). The project aims to determine the mechanism of action, pharmacokinetics, and pharmacological efficacy of FAL-113 in preclinical NASH models. FAL-113 is designed to simultaneously modulate...